Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CG | P48736 | 14/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | PIK3CD | O00329 | 12/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 10/20 | 0.47 |
| ▸ | PIK3CB | P42338 | 9/20 | 0.47 |
| ▸ | PIK3C3 | Q8NEB9 | 2/20 | 0.45 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.45 |
| ▸ | PIK3C2A | O00443 | 1/20 | 0.45 |
| ▸ | PIK3C2B | O00750 | 1/20 | 0.45 |
| ▸ | PI4KA | P42356 | 1/20 | 0.45 |
| ▸ | PRKDC | P78527 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1234690 | 0.85 | PIK3CG (0.61) | PIK3CGPIK3CDPIK3CAPIK3CBPIK3C3 | |
| SCHEMBL1237223 | 0.84 | PIK3CG (0.51) | PIK3CGALDH1A1PIK3CDPIK3CAPIK3CB | |
| SCHEMBL1237761 | 0.84 | PIK3CG (0.48) | PIK3CGPIK3CDPIK3CAPIK3CBPIK3C3 | |
| SCHEMBL1235063 | 0.84 | PIK3CD (0.65) | PIK3CGPIK3CDPIK3CAPIK3CBPIK3C3 | |
| SCHEMBL12713775 | 0.83 | PIK3CG (0.47) | PIK3CGMAPTPIK3CDPIK3CAPIK3CB | |
| SCHEMBL1235105 | 0.82 | ALDH1A1 (0.50) | PIK3CGALDH1A1PIK3CDPIK3CAPIK3CB | |
| SCHEMBL1236497 | 0.81 | PIK3CG (0.56) | PIK3CGALDH1A1MAPTHTTHSD17B10 | |
| SCHEMBL1236704 | 0.81 | PIK3CG (0.46) | PIK3CGPIK3CDPIK3CAPIK3CBPIK3C3 | |
| SCHEMBL1236714 | 0.81 | PIK3CG (0.50) | PIK3CGALDH1A1MAPTHTTHSD17B10 | |
| SCHEMBL1235217 | 0.79 | PIK3CG (0.55) | PIK3CGPIK3CDPIK3CAPIK3CBPIK3C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7888379-B2 | N-[5-(5-formyl-2-thienyl)-4-methyl-1,3-thiazol-2-yl]acetamide; autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer | MERCK SERONO SA (CH) | 2011-02-15 | — | — | US | claimed |
| US-20080200463-A1 | Thiazole Derivatives and Use Thereof | LABORATOIRES SERONO SA (CH) | 2008-08-21 | — | — | US | claimed |
| EP-1888573-A1 | THIAZOLE DERIVATIVES AND USE THEREOF | LABORATOIRES SERONO S.A. (CH) | 2008-02-20 | — | — | EP | claimed |
| WO-2006125807-A1 | THIAZOLE DERIVATIVES AND USE THEREOF | LABORATOIRES SERONO S.A. (CH) | 2006-11-30 | — | — | WO | claimed |
| US-20110071113-A1 | Thiazole Derivatives and Use Thereof | MERCK SERONO SA (CH) | 2011-03-24 | — | — | US | disclosed |
| US-20110071113-A1 | Thiazole Derivatives and Use Thereof | MERCK SERONO SA (CH) | 2011-03-24 | — | — | US | disclosed |
| US-20110071113-A1 | Thiazole Derivatives and Use Thereof | MERCK SERONO SA (CH) | 2011-03-24 | — | — | US | disclosed |
| US-7888379-B2 | N-[5-(5-formyl-2-thienyl)-4-methyl-1,3-thiazol-2-yl]acetamide; autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer | MERCK SERONO SA (CH) | 2011-02-15 | — | — | US | disclosed |
| US-7888379-B2 | N-[5-(5-formyl-2-thienyl)-4-methyl-1,3-thiazol-2-yl]acetamide; autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer | MERCK SERONO SA (CH) | 2011-02-15 | — | — | US | disclosed |
| US-7888379-B2 | N-[5-(5-formyl-2-thienyl)-4-methyl-1,3-thiazol-2-yl]acetamide; autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, bacterial or viral infections, kidney diseases, platelet aggregation, cancer | MERCK SERONO SA (CH) | 2011-02-15 | — | — | US | disclosed |
| US-20080200463-A1 | Thiazole Derivatives and Use Thereof | LABORATOIRES SERONO SA (CH) | 2008-08-21 | — | — | US | disclosed |
| US-20080200463-A1 | Thiazole Derivatives and Use Thereof | LABORATOIRES SERONO SA (CH) | 2008-08-21 | — | — | US | disclosed |
| US-20080200463-A1 | Thiazole Derivatives and Use Thereof | LABORATOIRES SERONO SA (CH) | 2008-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200463-A1 | Thiazole Derivatives and Use Thereof | PDGFRB, PDGFRA, TEC | PIK3CG 2526/4885ALDH1A1 174/4885MAPT 1418/4885 |
| US-20110071113-A1 | Thiazole Derivatives and Use Thereof | PDGFRB, PDGFRA, TEC | PIK3CG 2526/4885ALDH1A1 174/4885MAPT 1418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.